Logo
x

Search

Subscribe Now

relmada therapeutics

Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for ~$3.12M

Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for ~$3.12M

  • February 7, 2025
Relmada Therapeutics Reported Results for REL-1017 in the P-III Trial for the Treatment of Major Depressive Disorders

Relmada Therapeutics Reported Results for REL-1017 in the P-III Trial for the Treatment of Major Depressive Disorders

  • September 21, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.